FDNA (אפ.די.אן.איי)
Herzliya, Israel
FDNA develops AI technologies and SaaS platforms used by thousands of clinical, research, and lab sites globally in the clinical genomics space. Using advanced deep learning, FDNA's next-generation phenotyping technologies capture, structure, and analyze complex human physiological data to produce actionable genomic insights. FDNA's database includes a depth of phenotypic and genotypic information associated with more than 10,000 diseases, crowdsourced from real-world patient cases through a broad network of the company's users. This de-identified data is collected and stored in a private and secure cloud-based clinical warehouse and integrated to LIMS, EMR, and variant interpretation systems through a set of open APIs.
Company Info
- Founded
- 2011
- Website
- fdna.com/
Categories
Disease Areas
Technologies
Only accessible to MedStartr community members.
Join nowWhat do you think of FDNA (אפ.די.אן.איי)?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.